Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Update on Irrevocables

9 Feb 2009 11:39

RNS Number : 0075N
2 ergo Group plc
09 February 2009
 



THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

9 February 2009

RECOMMENDED PROPOSAL FOR THE ALL SHARE ACQUISITION

by

2 ergo Group plc

of

Broca plc

(to be effected by means of a scheme of arrangement)

Update on irrevocables

In addition to the irrevocable undertakings set out in the announcement of the recommended proposal for the all share acquisition by 2 ergo Group plc of Broca plc on 5 February 2009, the following Broca shareholder has given an irrevocable undertaking to vote in favour of the Scheme and the Resolutions at the Court Meeting and the General Meeting:

 

 

Name

No. of Ordinary Shares

% of Broca's issued share capital

% of Broca's issued share capital expected to be in issue and entitled to vote at the Court Meeting and General Meeting

Nigel Wray

2,345,530

6.00%

11.17%

 

This undertaking will lapse on the Scheme being withdrawn or lapsing or if the Scheme does not proceed if either: the Panel consents to 2 ergo not implementing the Scheme; an event occurs which means that 2 ergo is no longer required by the City Code to implement the Scheme; or 2 ergo becomes aware that any term or condition of the Scheme as set out in the Announcement has or may become incapable of being fulfilled or satisfied. In addition, if at any time prior to the Scheme becoming effective, lapsing or being withdrawn, a third party makes a materially higher competing offer to acquire the entire issued and to be issued share capital of Broca, where material in respect of a higher competing offer means an offer which exceeds the price per Broca Share offered under the Scheme by more than 10%, this undertaking may be revoked by the above shareholder serving written notice on 2 ergo.

2 ergo has therefore received irrevocable undertakings to vote in favour of the Scheme and the Resolutions at the Court Meeting and the General Meeting from:

each of the Broca Independent Directors in respect of their entire beneficial holdings of 766,706 Ordinary Shares representing at the date of this announcement approximately 1.96 per cent. of Broca's issued share capital (and 3.65 per cent. of Broca's issued share capital expected to be in issue and entitled to vote at the Court Meeting and the General Meeting). 

institutional and other Broca Shareholders in respect of 5,265,530 Ordinary Shares to which voting authority has been granted representing at the date of this announcement approximately 13.47 per cent. of Broca's issued share capital (and 25.07 per cent. of Broca's issued share capital expected to be in issue and entitled to vote at the Court Meeting and the General Meeting).

In aggregate, therefore, 2 ergo has received irrevocable undertakings to vote in favour of the Scheme and the Resolutions in respect of a total of 6,032,236 Ordinary Shares representing at the date of this announcement approximately 15.43 per cent. of the issued share capital of Broca (and 28.72 per cent. of Broca's issued share capital expected to be in issue and entitled to vote at the Court Meeting and the General Meeting).

This announcement is made pursuant to Rule 8 of the City Code. 

Defined terms used in this announcement shall (unless the context otherwise requires) have the same meanings set out in the announcement dated 5 February 2009 setting out the terms of the recommended proposal for the all share acquisition by 2 ergo of Broca.

Enquiries:

2 ergo Group plc

Tel: +44 (0) 1706 221 777

Neale Graham, Joint Chief Executive

Barry Sharples, Joint Chief Executive

Numis Securities Limited (financial adviser, nominated adviser and broker to 2 ergo)

Tel: +44 (0) 20 7260 1000

Stuart Skinner (as Nominated Adviser)

David Poutney (as Corporate Broker)

RSM Bentley Jennison (financial adviser to 2 ergo)

Tel: +44 (0) 161 819 3030

David Simmons

Broca plc

Tel: +44 (0) 845 006 6661 

Ian Price, Chief Executive

Grant Thornton UK LLP (financial adviser and nominated adviser to Broca)

Tel: +44 (0) 20 7383 5100

Fiona Owen

Littlejohn (financial adviser to Broca)

Tel: +44 (0) 20 7516 2210

Claire Palmer

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPUUUAWPUPBGGB
Date   Source Headline
20th Aug 20185:10 pmRNSSale of Castleton Shares
14th Aug 20187:00 amRNSConversion of Loan Notes in Castleton Technology
6th Aug 20181:30 pmRNSHolding(s) in Company
6th Aug 20181:30 pmRNSHolding(s) in Company
6th Aug 20187:00 amRNSFurther Investment / Sale of Shares
31st Jul 20187:00 amRNSProposed investment in IDE Group Holdings
19th Jul 20187:00 amRNSAcquisition by Ravenscroft of 25% shareholding
21st Jun 20188:25 amRNSHolding(s) in Company
21st Jun 20187:56 amRNSSale of Castleton Shares
12th Jun 201810:18 amRNSIssue of Equity / Total Voting Rights
30th May 20187:00 amRNSSubscription for Loan Notes in IDE Group Holdings
9th May 20187:00 amRNSInterim Results
23rd Apr 20187:00 amRNSFirst Investment into Joint Venture Liberty Global
11th Apr 20181:46 pmRNSPurchase of IDE Shares
10th Apr 20187:00 amRNSSale of Castleton Shares
21st Feb 20187:00 amRNSExercise of Castleton Option
16th Feb 20187:00 amRNSAppointed consultant to Ravenscroft Limited
13th Feb 20181:54 pmRNSResult of AGM
29th Jan 20187:00 amRNSPosting of Annual Report and Accounts
4th Dec 20177:00 amRNSBoard Change
4th Dec 20177:00 amRNSFinal Results for the Year Ended 31 August 2017
22nd Nov 20174:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20174:35 pmRNSPrice Monitoring Extension
21st Nov 20172:36 pmRNSIssue of Equity / Total Voting Rights
20th Nov 20177:00 amRNSJoint Venture with Liberty Global
3rd Nov 201712:54 pmRNSNotice of Annual Results
21st Sep 20172:02 pmRNSHolding(s) in Company
25th Aug 201710:20 amRNSTransaction in Own Shares / Total Voting Rights
1st Aug 20177:00 amRNSResignation as Financial Adviser to CORETX
30th Jun 20174:19 pmRNSTransaction in Own Shares / Total Voting Rights
30th Jun 201710:15 amRNSTransaction in Own Shares / Total Voting Rights
28th Jun 20171:56 pmRNSTransaction in Own Shares / Total Voting Rights
27th Jun 20175:13 pmRNSTransaction in Own Shares / Total Voting Rights
26th Jun 201711:48 amRNSTransaction in Own Shares / Total Voting Rights
23rd Jun 20174:23 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Jun 201711:36 amRNSTransaction in Own Shares / Total Voting Rights
21st Jun 20173:28 pmRNSTransaction in Own Shares / Total Voting Rights
21st Jun 201712:41 pmRNSTransaction in Own Shares / Total Voting Rights
15th Jun 20174:17 pmRNSTransaction in Own Shares / Total Voting Rights
13th Jun 20179:30 amRNSTransaction in Own Shares / Total Voting Rights
9th Jun 20171:42 pmRNSTransaction in Own Shares/ Total Voting Rights
8th Jun 20175:18 pmRNSTransaction in Own Shares/ Total Voting Rights
6th Jun 20174:22 pmRNSTransaction in Own Shares / Total Voting Rights
5th Jun 20174:33 pmRNSTransaction in Own Shares / Total Voting Rights
31st May 20175:27 pmRNSTransaction in own shares/Total voting rights
31st May 20179:46 amRNSTransaction in Own Shares/ Total Voting Rights
25th May 20174:20 pmRNSTransaction in Own Shares / Total Voting Rights
24th May 20174:14 pmRNSTransaction in Own Shares
24th May 201710:17 amRNSTransaction in Own Shares / Total Voting Rights
22nd May 20176:11 pmRNSTransaction in Own Shares / Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.